Edition:
United States

ChemoCentryx Inc (CCXI.OQ)

CCXI.OQ on NASDAQ Stock Exchange Global Select Market

11.03USD
17 Aug 2018
Change (% chg)

$0.08 (+0.73%)
Prev Close
$10.95
Open
$11.00
Day's High
$11.13
Day's Low
$10.60
Volume
81,258
Avg. Vol
91,765
52-wk High
$15.08
52-wk Low
$5.45

Chart for

About

ChemoCentryx, Inc. is a biopharmaceutical company. The Company is engaged in developing new medications targeted at inflammatory disorders, autoimmune diseases and cancer. Each of its drug candidates focuses on a specific chemoattractant receptor that selectively blocks its negative inflammatory or suppressive response, leaving... (more)

Overall

Beta: 1.31
Market Cap(Mil.): $555.68
Shares Outstanding(Mil.): 50.38
Dividend: --
Yield (%): --

Financials

  CCXI.OQ Industry Sector
P/E (TTM): 40.18 28.29 30.45
EPS (TTM): 0.27 -- --
ROI: 14.38 12.92 12.63
ROE: 48.14 14.94 14.82

BRIEF-Chemocentryx Q1 Revenue $9.5 Million Versus $8.2 Million

* CHEMOCENTRYX REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND RECENT HIGHLIGHTS

May 09 2018

BRIEF-Chemocentryx Q4 Revenue $56.3 Million Versus $4.9 Million

* CHEMOCENTRYX REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND RECENT HIGHLIGHTS

Mar 09 2018

Competitors

Earnings vs. Estimates